GEN 与 Sulfateq BV 公布治疗阿尔茨海默病及其他神经退行性疾病的候选药物 SUL-238 的第一阶段临床试验积极结果 Jul 29, 2025 08:00 HKT |  |
|
GEN 與 Sulfateq BV 公佈治療阿茲海默症及其他神經退化性疾病的候選藥物 SUL-238 的第一階段臨床試驗正面結果 Jul 29, 2025 08:00 HKT |  |
|
China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China Jul 29, 2025 04:00 HKT |  |
|
GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases Jul 28, 2025 20:00 HKT |  |
|
維立志博於聯交所主板成功上市 Jul 25, 2025 19:36 HKT |  |
|
维立志博于联交所主板成功上市 Jul 25, 2025 18:00 HKT |  |
|
亿胜生物多剂量地夸磷索钠滴眼液获中国国家药品监督管理局批准上市 Jul 25, 2025 10:52 HKT |  |
|
億勝生物多劑量地誇磷索鈉滴眼液獲中國國家藥品監督管理局批准上市 Jul 25, 2025 10:52 HKT |  |
|
Multi-Dose Diquafosol Sodium Eye Drops Obtained Approval from NMPA for Commercialisation in China Jul 25, 2025 10:52 HKT |  |
|
云顶新耀宣布配售股份 拟集资约15.725亿港元 Jul 25, 2025 10:01 HKT |  |
|
雲頂新耀宣布配售股份 擬集資約15.725億港元 Jul 25, 2025 10:01 HKT |  |
|
Everest Medicines Announces Share Placement to Raise Approximately HK$1,572.50 Million Jul 25, 2025 10:01 HKT |  |
|
镁信健康携手多方力量 共促粤港澳大湾区医疗保险发展 Jul 25, 2025 09:55 HKT | |
|
鎂信健康攜手多方力量 共促粵港澳大灣區醫療保險發展 Jul 25, 2025 09:55 HKT | |
|
HKTDC Research Report: Exploring Opportunities in Hong Kong's Proprietary Chinese Medicine Industry Jul 24, 2025 17:43 HKT |  |
|
아반토코리아, 수원 사무실 광교중앙역 인근으로 이전 Jul 24, 2025 09:00 HKT |  |
|
Avantor Relocates Korea Office in Suwon to Support Growth and Enhance Collaboration Jul 24, 2025 09:00 HKT |  |
|
冠科生物圣地亚哥实验室获 CLIA 认证 增强临床试验支持能力 Jul 23, 2025 09:00 HKT |  |
|
冠科生物聖地牙哥實驗室獲 CLIA 認證 增強臨床試驗支援能力 Jul 23, 2025 09:00 HKT |  |
|
CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets Jul 22, 2025 13:00 HKT |  |
|
Next >>
|